Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
◆ Two insurers announce capital deal mandates◆ Bermuda tier one offers unique reset structure ◆ Bupa opts for sterling tier two
-
Over 200 US stores parcelled, triple-As at 175bp over J-curve
-
Conditions attractive for convertible issuers to refinance
-
Several European IPOs are running despite US attacks on Iran
-
European IPOs expected next month
-
Company said the financing will help it take advantage of opportunities in the development of metabolic drugs